JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 52 filers reported holding JUNIPER PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,220,000 | -17.8% | 255,131 | -4.2% | 0.46% | -11.9% |
| Q1 2018 | $2,702,000 | +153.5% | 266,193 | +21.1% | 0.52% | +107.5% |
| Q4 2017 | $1,066,000 | +62.0% | 219,739 | +52.0% | 0.25% | +68.0% |
| Q3 2017 | $658,000 | +8.6% | 144,565 | +20.4% | 0.15% | -11.8% |
| Q2 2017 | $606,000 | +17.9% | 120,035 | +10.8% | 0.17% | +22.3% |
| Q1 2017 | $514,000 | +9.1% | 108,315 | +28.9% | 0.14% | +3.0% |
| Q4 2016 | $471,000 | +6.3% | 84,045 | +5.4% | 0.14% | +5.5% |
| Q3 2016 | $443,000 | -30.2% | 79,745 | -11.9% | 0.13% | -50.2% |
| Q2 2016 | $635,000 | +6.2% | 90,525 | 0.0% | 0.26% | +14.7% |
| Q1 2016 | $598,000 | +57.0% | 90,525 | +144.5% | 0.22% | +25.8% |
| Q4 2015 | $381,000 | – | 37,017 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 481,459 | $5,672,000 | 2.05% |
| Krensavage Asset Management, LLC | 279,717 | $3,295,000 | 1.19% |
| EAM Investors, LLC | 145,898 | $1,719,000 | 0.27% |
| PERRITT CAPITAL MANAGEMENT INC | 93,000 | $1,096,000 | 0.23% |
| TFS CAPITAL LLC | 99,823 | $1,176,000 | 0.11% |
| Bellevue Asset Management AG | 50,000 | $589,000 | 0.10% |
| CADENCE CAPITAL MANAGEMENT LLC | 88,232 | $1,039,000 | 0.07% |
| Spark Investment Management LLC | 39,200 | $461,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 100,564 | $1,185,000 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 35,599 | $419,000 | 0.03% |